Eun Jig Lee

Title: Eun Jig Lee: Innovator in Fusion Protein Technology

Introduction

Eun Jig Lee is a prominent inventor based in Seoul, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. Her innovative work has the potential to impact therapeutic and diagnostic applications.

Latest Patents

Eun Jig Lee holds a patent for a fusion protein comprising thyrotropin receptor variants. This patent discloses a fusion protein that includes a thyrotropin receptor (TSHR) fragment, specifically an extracellular domain of a wild-type TSHR with an amino acid substitution at a specific position. The fusion protein is combined with an immunoglobulin Fc region or a carboxy-terminal cap (C-CAP). This invention demonstrates improved pharmaceutical efficacy, in-vivo persistence, and protein stability. The pharmaceutical composition containing this fusion protein serves as a therapeutic agent or diagnostic reagent for alleviating Graves' disease and Graves' ophthalmopathy.

Career Highlights

Eun Jig Lee has worked with notable organizations, including Yuhan Corporation and Yonsei University. Her experience in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.

Collaborations

Eun Jig Lee has collaborated with esteemed colleagues such as Moo Young Song and Taejin Yoon. These partnerships have further enhanced her research and development efforts in the biotechnology sector.

Conclusion

Eun Jig Lee is a trailblazer in the field of fusion protein technology, with her innovative patent addressing critical health issues. Her work exemplifies the intersection of science and medicine, showcasing the potential of biotechnology to improve patient outcomes.